Partners

Our International Network of Partners

Meeting our ambitious goals will not be possible without the committed engagement of our many partners across Alberta, Canada and the World. We are extremely grateful.

map

Medical Institutions

Prostate Cancer Centre (Calgary)

Northern Alberta Urology Centre (Edmonton)

Alberta Health Services (Alberta)

Vancouver Prostate Cancer Centre (Vancouver)

The Prostate Centre at The Princess Margaret Hospital (Toronto)

CHUM Groupe de soutien du cancer de la prostate (Montreal)

London Regional Cancer Program (London, ON)

Technology Platforms

Malvern (UK)

APOGEE (UK)

Nanosight

BGI Genomics (China)

Precision Nanosystems (BC)

Universities

University of Alberta (Edmonton, AB)

University of Calgary (Calgary, AB)

Western University (London, ON)

Dalhousie University (Halifax, NS)

University of Toronto (Toronto, ON)

Vanderbilt University (Nashville, TN)

Case Western Reserve University (Cleveland, OH)

Fraunhofer ITEM-R (Regensburg, Germany)

Biorepositories

Alberta Cancer Research Biobank (Calgary, Edmonton)

Australian Prostate Cancer BioResource (Australia: Melbourne, Sydney, Brisbane and Adelaide)

OICR Tumour Bank (Ontario)

Tomorrow Project 

UHN GU BioBank

Canadian Biosample Repository

Canadian Prostate Cancer Biomarker Network

Financial Resources

Alberta Cancer Foundation (Alberta)

Movember Foundation (Australia, Canada)

Terry Fox Research Institute (Canada)

Motorcycle Ride for Dad (Canada)

Prostate Cancer Canada

Alberta Innovates Health Solutions – Collaborative Research and Innovation opportunities

Alberta Lymphedema Network (Edmonton, Alberta)

University Hospital Foundation – J & J Partnership

Support Groups

Prostate Cancer Canada Network (Canada)

Prostate Cancer Canada Network (Calgary)

Prostate Cancer Canada Network (Edmonton)

The Alberta Prostate Cancer Biorepository is certified by CTRNet

APCaRI is committed to collecting, processing and storing the samples you donate with the highest quality standards and as a result, after evaluation of our processes, the CTRNet (Canadian Tissue Repository Network) awarded us with their certification.

CTRNet is a translational cancer research resource, funded by Canadian Institutes of Health Research, that furthers Canadian health research by linking cancer researchers with provincial tumour banks.

The benefits of working with CTRNet include:

  • The ability for researchers to search for quality controlled tissue samples from Canada’s leading tumour banks in one central location and for biobanks to display and make their biospecimens available for research users.
  • Learning opportunities in tissue handling, research design and relevant technology training and innovations.
  • Invitation to CTRNet workshops and conferences.
- Catalina Vasquez